Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Nicol Keith

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
European Urology|January 22, 2005
Application of targeted radiotherapy/gene therapy to bladder cancer cell linesNatasha E Fullerton, Robert J Mairs, David Kirk, et al.
Neoplasia (New York, N.Y.)|April 8, 2004
Zoning of mucosal phenotype, dysplasia, and telomerase activity measured by telomerase repeat assay protocol in Barrett's esophagusJames J Going, Aileen J Fletcher-Monaghan, Lisa Neilson, et al.
Drug Discovery Today|February 9, 2012
Cancer cell senescence: a new frontier in drug developmentClaire J Cairney, Alan E Bilsland, T R Jeffry Evans, et al.
Current Protocols in Cell Biology|June 5, 2014
Isolation, culture, and transfection of melanocytesLauren S Godwin, Joanna T Castle, Jaskaren S Kohli, et al.
Neoplasia (New York, N.Y.)|August 12, 2019
A Novel Pyrazolopyrimidine Ligand of Human PGK1 and Stress Sensor DJ1 Modulates the Shelterin Complex and Telomere Length RegulationAlan E Bilsland, Yu Liu, Andrew Turnbull, et al.
Future Oncology (London, England)|July 22, 2014
Plasma N-acetyl-glucosaminidase in advanced gastro-intestinal adenocarcinoma correlates with age, stage and outcomeDaniel Hartmann, Guido von Figura, Zhangfa Song, et al.
Neoplasia (New York, N.Y.)|July 29, 2014
Immortalization of T-cells is accompanied by gradual changes in CpG methylation resulting in a profile resembling a subset of T-cell leukemiasSofie Degerman, Mattias Landfors, Jan Konrad Siwicki, et al.
The Journal of Gene Medicine|August 5, 2004
An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effectsMarie Boyd, Robert J Mairs, W Nicol Keith, et al.
BMC Blood Disorders|June 24, 2004
A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal HaemoglobinuriaW Nicol Keith, Tom Vulliamy, Jiangqin Zhao, et al.
Plos One|August 4, 2009
Dynamic telomerase gene suppression via network effects of GSK3 inhibitionAlan E Bilsland, Stacey Hoare, Katrina Stevenson, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
European Urology|January 22, 2005
Application of targeted radiotherapy/gene therapy to bladder cancer cell linesNatasha E Fullerton, Robert J Mairs, David Kirk, et al.
Neoplasia (New York, N.Y.)|April 8, 2004
Zoning of mucosal phenotype, dysplasia, and telomerase activity measured by telomerase repeat assay protocol in Barrett's esophagusJames J Going, Aileen J Fletcher-Monaghan, Lisa Neilson, et al.
Drug Discovery Today|February 9, 2012
Cancer cell senescence: a new frontier in drug developmentClaire J Cairney, Alan E Bilsland, T R Jeffry Evans, et al.
Current Protocols in Cell Biology|June 5, 2014
Isolation, culture, and transfection of melanocytesLauren S Godwin, Joanna T Castle, Jaskaren S Kohli, et al.
Neoplasia (New York, N.Y.)|August 12, 2019
A Novel Pyrazolopyrimidine Ligand of Human PGK1 and Stress Sensor DJ1 Modulates the Shelterin Complex and Telomere Length RegulationAlan E Bilsland, Yu Liu, Andrew Turnbull, et al.
Future Oncology (London, England)|July 22, 2014
Plasma N-acetyl-glucosaminidase in advanced gastro-intestinal adenocarcinoma correlates with age, stage and outcomeDaniel Hartmann, Guido von Figura, Zhangfa Song, et al.
Neoplasia (New York, N.Y.)|July 29, 2014
Immortalization of T-cells is accompanied by gradual changes in CpG methylation resulting in a profile resembling a subset of T-cell leukemiasSofie Degerman, Mattias Landfors, Jan Konrad Siwicki, et al.
The Journal of Gene Medicine|August 5, 2004
An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effectsMarie Boyd, Robert J Mairs, W Nicol Keith, et al.
BMC Blood Disorders|June 24, 2004
A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal HaemoglobinuriaW Nicol Keith, Tom Vulliamy, Jiangqin Zhao, et al.
Plos One|August 4, 2009
Dynamic telomerase gene suppression via network effects of GSK3 inhibitionAlan E Bilsland, Stacey Hoare, Katrina Stevenson, et al.
Pageof 7